contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

CEO, Sweden

Claus Thestrup

Gubra er en medicinalvirksomhed. Virksomhedens aktiviteter er fokuseret på de tidlige stadier af lægemiddeludvikling. De udfører hovedsageligt forskning og udvikling inden for stofskifte- og fibrotiske sygdomme.Virksomhedens produktportefølje omfatter flere brands og lægemidler, og aktiviteterne foregår på globalt plan med den største tilstedeværelse i Nordamerika og Norden. Hovedkontoret ligger i Hørsholm, Danmark.

Gubra

Gubra: Opjustering af guidance for 2023
V&#xe6;ksten i CRO-forretningen er rigtig st&#xe6;rk indenfor samtlige sygdomsomr&#xe5;der. I den seneste opjustering af 2023 guidance den 15. august 2023 var det blandt andet Lever og Nyre, men nu n&#xe6;vner Gubra ligeledes Fedme som anledningen til opjusteringen. Guidance for D&amp;P er u&#xe6;ndret ift. tidligere og viser styrken i Gubra forretningsmodel. Aktien lukkede i kurs 94,21 (+0,01&#x2009;%). Orderbogen er rigtig god, hvilket giver en indikation for 2024.
Hvordan ser den nye guidance vs. tidligere.
Opjusteret outlook for 2023
<div class="table-wrapper"><table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Key ratio</td>
<td colspan="1" rowspan="1">Nyt outlook for 2023</td>
<td colspan="1" rowspan="1">Tidligere outlook for 2023</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CRO Segment</td>
<td colspan="1" rowspan="1">&#xa0;</td>
<td colspan="1" rowspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Organic oms&#xe6;tningsv&#xe6;kst vs. 2022</td>
<td colspan="1" rowspan="1">25-28%</td>
<td colspan="1" rowspan="1">16-21%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EBIT-margin excl. special items</td>
<td colspan="1" rowspan="1">26-28%</td>
<td colspan="1" rowspan="1">omkring 25%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&#xa0;</td>
<td colspan="1" rowspan="1">&#xa0;</td>
<td colspan="1" rowspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Discovery &amp; Partnership Segment</td>
<td colspan="1" rowspan="1">&#xa0;</td>
<td colspan="1" rowspan="1">&#xa0;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Antal nye partnerships</td>
<td colspan="1" rowspan="1">1-2 nye partnerskaber</td>
<td colspan="1" rowspan="1">1-2 nye partnerskaber</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total omkostninger* ekslusiv special Items</td>
<td colspan="1" rowspan="1">DKK 105-110 million</td>
<td colspan="1" rowspan="1">DKK 105-110 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total omkostninger* ekslusiv&#xa0; Amylin Pipeline Asset og special Items</td>
<td colspan="1" rowspan="1">DKK 85-95 million</td>
<td colspan="1" rowspan="1">DKK 85-95 million</td>
</tr>
</tbody>
</table></div>
* Omkostninger som andel af salg og driftsomkostninger.
Yderligere detaljer omkring udviklingen i 3. kvartal 2023 vil blive offentliggjort ifm. regnskabet den 8. november 2023.
L&#xe6;s hele meddelelsen her: <a href="https://www.gubra.dk/mfn_news/gubra-raises-financial-guidance-for-full-year-2023-2/" target="_blank" rel="noopener">Gubra opjustering</a>
Disclaimer: HC Andersen Capital modtager betaling fra Gubra for en Digital IR/Corporate Visibility abonnementsaftale. /Claus Thestrup&#xa0; kl. 8:35 d. 26/10-2023

Key ratio	Nyt outlook for 2023	Tidligere outlook for 2023
CRO Segment
Organic omsætningsvækst vs. 2022	25-28%	16-21%
EBIT-margin excl. special items	26-28%	omkring 25%

Discovery & Partnership Segment
Antal nye partnerships	1-2 nye partnerskaber	1-2 nye partnerskaber
Total omkostninger* ekslusiv special Items	DKK 105-110 million	DKK 105-110 million
Total omkostninger* ekslusiv Amylin Pipeline Asset og special Items	DKK 85-95 million	DKK 85-95 million